🔗 Share this article

An high-ranking health figure has been recused from oversight in an major research project into hormone suppressants after accusations regarding bias surfaced.

Reported Involvement Resulted in Study Halt

According to news reports, Professor Jacob George, a chief medical director at the medicines regulator, raised concerns which led to the halting of a government-backed clinical study in the winter.

This regulator stated this weekend how George was recusing himself of involvement with the trial after gender-critical online posts made in the past came to light.

Content Regarding the Social Media Comments

Among one statement, he referred to writer the Harry Potter author as a valuable figure in modern society.” In another, he stated that the refusal of basic biological fact was troubling” in regards to discussions about a Olympic athlete’s gender.

The regulator said how while George’s comments occurred prior to the role began, he was recused of involvement with the trial as an preventative measure.

Details of the Paused Pathways Trial

This Pathways trial, which was designed to evaluate the impact from puberty blockers on young people exploring their gender identity, was due to commence recruiting volunteers in the start of the year.

However, the trial was halted in the following month once its medicines regulator raised concerns over the wellbeing of young participants taking part.

• The most junior participants were projected to start at ten to eleven among girls while eleven to twelve among boys.
• Its study team stated at the time that the thorough selection procedure indicated participants would almost certainly be more mature.
• However, the agency has now said the minimum age threshold must be 14 owing to the unknown danger” for lasting physical side effects.”

This study had planned to recruit a projected two hundred and twenty-six young people during the coming three years.

Background Following a Cass Review

The trial was commissioned following a suggestion from an independent inquiry on children’s gender identity services, that concluded how the quality of research claiming to demonstrate the benefits from such treatment in adolescents with gender incongruence were “poor.”

Dr Hilary Cass, who led the review, once commented the report revealed an extremely poor evidence base” for the usefulness of such treatments.

Dr. Cass continued, since there are clinicians, young people as well as families who believe strongly of the positive outcomes, research was the necessary step forward to make sense of this.”

Expert Concern Regarding the Decision

Doctor Max Davie, an expert in adolescent medicine, stated there existed no strong medical rationale to pause the study.

“The social media posts by Prof George give a transparent view of his personal views on this issue,” Dr. Davie stated. “The professor is quite at liberty to have whatever views on this subject he wishes, but what he cannot do is let these opinions to affect the performance of his regulatory responsibilities.”

The doctor continued: “It must be understood, there exists no compelling scientific reason to stop this study. Although the professor’s own views are not the only plausible cause of the regulator’s abrupt change of position, it is the single factor for which we have proof.”

Regulator Response and Next Steps

A regulatory representative said: “In all medical studies, the MHRA’s foremost duty is the protection and welfare for those involved. In line with that commitment, detailed studies are kept continuously under scrutiny while the agency keeps an active discussion alongside trial sponsors.”

“The MHRA have expert scientific, medical and oversight experts who work as a cross-functional team to provide scientifically sound judgments regarding clinical trials. These individuals will continue to meet alongside the research team to work through the future path in a positive manner.”

“Subsequent to the finding regarding social media posts posted before his appointment, Prof Jacob George has been recused from continued oversight regarding the Pathways study as a preventative step.”